<DOC>
	<DOC>NCT02782663</DOC>
	<brief_summary>This is a open-label extension (OLE) study designed to evaluate the long-term efficacy, safety, and tolerability of ABT-494.</brief_summary>
	<brief_title>A Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of ABT-494 in Subjects With Crohn's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>Participant must have completed Study M13740 through Week 52. If female, participant must be postmenopausal, surgically sterile or on using a birth control method. For any reason participant is considered by the investigator to be an unsuitable candidate Female participant with a positive pregnancy test at Baseline or who is considering becoming pregnant during the study. Participant is not in compliance with prior and concomitant medication requirements and procedures throughout Study M13740.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Crohn's Disease</keyword>
	<keyword>Tolerability</keyword>
	<keyword>ABT-494</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Safety</keyword>
</DOC>